Skip to main content
BBIO logo
BBIO
(NASDAQ)
BridgeBio Pharma, Inc.
$73.15-- (--)
Loading... - Market loading

BridgeBio Pharma, Inc. (BBIO) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for BridgeBio Pharma, Inc. stock.

Analyst Consensus Rating

Investment consensus from 25 professional research analysts

Consensus Rating

Buy
Based on 25 unique analysts
(38 total ratings in last 90 days)
Very High Confidence:1 Buy/Sell

Average Price Target

$97.17
32.84% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest BBIO Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Salim Syed
Mizuho
BuyMaintains
$91.00 $106.00
Jason Zemansky
BofA Securities
BuyMaintains
$95.00
Paul Choi
Goldman Sachs
BuyMaintains
$71.39 $112.00
John Boylan
William Blair
BuyInitiates
-
Anupam Rama
JP Morgan
BuyMaintains
$89.00 $94.00
Ram Selvaraju
HC Wainwright
BuyReiterates
$100.00
Joshua Schimmer
Cantor Fitzgerald
BuyReiterates
$110.00
Biren Amin
Piper Sandler
BuyMaintains
$98.00 $111.00
Danielle Brill
Truist
Strong BuyMaintains
$86.00 $95.00
Tyler Van Buren
TD Cowen
BuyMaintains
$95.00
Eliana Merle
Barclays
BuyMaintains
$157.00
Jason Zemansky
BofA Securities
BuyReiterates
$95.00
Trevor Allred
Oppenheimer
BuyMaintains
$83.00 $81.00
Cory Kasimov
Evercore ISI Group
BuyMaintains
$100.00 $125.00
Sean Laaman
Morgan Stanley
BuyMaintains
$96.00 $98.00
Raghuram Selvaraju
HC Wainwright
Strong BuyMaintains
$90.00 $100.00
Derek Archila
Wells Fargo
BuyMaintains
$88.00 $98.00
Trevor Allred
Oppenheimer
BuyMaintains
$81.00 $83.00
William Pickering
Bernstein
BuyInitiates Coverage
$100.00
Biren Amin
Piper Sandler
BuyMaintains
$98.00
Cory Kasimov
Evercore ISI Group
BuyMaintains
$100.00
Sean Laaman
Morgan Stanley
BuyMaintains
$96.00
Joshua Schimmer
Cantor Fitzgerald
BuyMaintains
$110.00
Eliana Merle
Barclays
BuyInitiates
$80.00
Google Biotechnology
TipRanks - Google
BuyReiterates
$86.00 $89.00
PerPlexity Biotechnology
TipRanks - PerPlexity
HoldReiterates
$78.00 $76.00
Anthropic Biotechnology
TipRanks - Anthropic
HoldReiterates
$75.00 $80.00
DeepSeek Biotechnology
TipRanks - DeepSeek
HoldReiterates
$78.00 $81.00
xAi Biotechnology
TipRanks - xAI
HoldReiterates
$74.00 $79.00
OpenAI Biotechnology
TipRanks - OpenAI
HoldReiterates
$75.00 $80.00
Derek Archila
Wells Fargo
BuyMaintains
$84.00 $88.00
Martin Auster
Raymond James
BuyReiterates
$76.62 $85.00
Cory Kasimov
Evercore ISI Group
BuyMaintains
$90.00 $100.00
Danielle Brill
Truist
BuyMaintains
-
Biren Amin
Piper Sandler
BuyMaintains
$98.00
Danielle Brill
Truist
Strong BuyMaintains
$80.00 $86.00
Andrew Tsai
Jefferies
BuyMaintains
$85.00
Sean Laaman
Morgan Stanley
BuyInitiates
$96.00

Frequently Asked Questions

What is the analyst consensus rating for BBIO?

The analyst consensus rating for BBIO is "Buy" based on 25 analyst recommendations.

What is the average price target for BBIO?

The average 12-month price target for BBIO is $97.17, representing an upside of 32.8% from the current price of $73.15.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.